Role of histone deacetylases in pancreas: Implications for pathogenesis and therapy

This publication has 87 references indexed in Scilit:

• Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases
  Drug Discovery Today, 2014
• Histone deacetylases as targets for treatment of multiple diseases
  Clinical Science, 2013
• Myeloid, but Not Pancreatic, RelA/p65 Is Required for Fibrosis in a Mouse Model of Chronic Pancreatitis
  Gastroenterology, 2011
• Romidepsin for the treatment of cutaneous T-cell lymphoma
  Drugs of Today, 2009
• Expression of Hypoxia-Inducible Factor-1α, Histone Deacetylase 1, and Metastasis-Associated Protein 1 in Pancreatic Carcinoma
  Pancreas, 2008
• Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
  Journal of Clinical Oncology, 2007
• The pancreatic stellate cell: a star on the rise in pancreatic diseases
  Journal of Clinical Investigation, 2007
• β-Catenin is essential for pancreatic acinar but not islet development
  Development, 2005
• Cytokine storm in acute pancreatitis
  Journal of Hepato-Biliary-Pancreatic Surgery, 2002
• Cyclin G2 Associates with Protein Phosphatase 2A Catalytic and Regulatory B′ Subunits in Active Complexes and Induces Nuclear Aberrations and a G1/S Phase Cell Cycle Arrest
  Journal of Biological Chemistry, 2002